Chronic Expression of a Clinical <i>SFTPC</i> Mutation Causes Murine Lung Fibrosis with Idiopathic Pulmonary Fibrosis Features-Reference-Cited by-同舟云学术

Chronic Expression of a Clinical SFTPC Mutation Causes Murine Lung Fibrosis with Idiopathic Pulmonary Fibrosis Features

Published:2023-04 Issue:4 Volume:68 Page:358-365
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Rodriguez Luis¹,Tomer Yaniv¹,Carson Paige¹,Dimopoulos Thalia¹,Zhao Ming¹,Chavez Katrina¹,Iyer Swati¹,Huang Li²,Ebert Christina²,Sereda Larisa²,Murthy Aditi¹,Trujillo Glenda²,Beers Michael F.¹³⁴^ORCID,Katzen Jeremy¹³^ORCID

Affiliation:

1. Pulmonary, Allergy, and Critical Care Medicine Division and

2. Fibrosis Biology Drug Discovery, Bristol-Myers Squibb, Lawrenceville, New Jersey; and

3. PENN–CHOP Lung Biology Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania;

4. The Michael Crescenz VA Medical Center, Philadelphia, Pennsylvania

Funder

National Heart, Lung, and Blood Institute

Department of Veterans Affairs, Australian Government

Bristol Myers Squibb IDEAL Consortium 2.0

Pulmonary Fibrosis Foundation

Parker B Francis Foundation

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

https://www.atsjournals.org/doi/pdf/10.1165/rcmb.2022-0203MA

Reference36 articles.

1. Idiopathic Pulmonary Fibrosis

2. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis

3. Ineffectual Type 2–to–Type 1 Alveolar Epithelial Cell Differentiation in Idiopathic Pulmonary Fibrosis: Persistence of the KRT8hi Transitional State

4. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report — 2021; Focus on recipient characteristics

5. An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alveolar type 2 cells marker gene SFTPC inhibits epithelial-to-mesenchymal transition by upregulating SOX7 and suppressing WNT/β-catenin pathway in non-small cell lung cancer;Frontiers in Oncology;2024-09-13

2. Activation of alveolar epithelial ER stress by β-coronavirus infection disrupts surfactant homeostasis in mice: implications for COVID-19 respiratory failure;American Journal of Physiology-Lung Cellular and Molecular Physiology;2024-08-01

3. A roadmap to precision treatments for familial pulmonary fibrosis;eBioMedicine;2024-06

4. Effects of Natural Products through Inhibiting Endoplasmic Reticulum Stress on Attenuation of Idiopathic Pulmonary Fibrosis;Drug Design, Development and Therapy;2024-05

5. Lung regeneration: diverse cell types and the therapeutic potential;MedComm;2024-02